Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion type Assertion NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_head.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion description "[Epidermal growth factor receptor 2 (HER2) overexpression is observed at a higher rate in IBC compared with noninflammatory breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_provenance.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion evidence source_evidence_literature NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_provenance.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion SIO_000772 24886365 NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_provenance.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion wasDerivedFrom befree-2016 NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_provenance.
- NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_assertion wasGeneratedBy ECO_0000203 NP1187756.RA6-cwLznsSl725lOKnLMJiKxbuqeKQ-EjoK2D38nT6tI130_provenance.